Signal active
Organization
Contact Information
Overview
AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.
Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.
About
Biotechnology, Health Care, Medical
2003
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
AngioScore headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $4.2B in funding across 48 round(s). With a team of 51-100 employees, AngioScore is actively contributing to advancements in Biotechnology. Their latest funding round, Series E - AngioScore, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
6
0
$87.0M
Details
3
AngioScore has raised a total of $87.0M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2006 | Late Stage Venture | 30.0M | ||
2004 | Early Stage Venture | 15.0M | ||
2007 | Late Stage Venture | 30.0M |
Investors
AngioScore is funded by 19 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Innomed Ventures | - | FUNDING ROUND - Innomed Ventures | 15.0M |
Jim Dreyfous | - | FUNDING ROUND - Jim Dreyfous | 15.0M |
AngioScore | - | FUNDING ROUND - AngioScore | 15.0M |
Pelion Venture Partners | - | FUNDING ROUND - Pelion Venture Partners | 15.0M |
Recent Activity
There is no recent news or activity for this profile.